Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances 16. July 2018, section EUDA news
5. January 2026 EU Drugs Agency welcomes its new Executive Director, Dr Lorraine Nolan This week, the European Union Drugs Agency (EUDA) welcomes its new Executive Director Dr Lorraine Nolan (Ireland), as she...